17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Differential diagnosis<br />

The much more common situation of a<br />

cervical squamous cell <strong>carcinoma</strong> extending<br />

into the endometrium must be excluded.<br />

Predominantly squamous diff e re n t i a-<br />

tion of an endometrioid adenocarc i n o m a<br />

must also be excluded before making the<br />

diagnosis of primary pure squamous cell<br />

c a rcinoma of the endometrium.<br />

Prognosis and predictive factors<br />

The prognosis of most squamous cell<br />

<strong>carcinoma</strong>s of the endometrium is rather<br />

poor, although the verrucous variant may<br />

be more favourable.<br />

Transitional cell <strong>carcinoma</strong><br />

Fig. 4.11 Clear cell adeno<strong>carcinoma</strong> of the endometrium. The tumour has a predominantly solid pattern with<br />

occasional poorly formed tubules. The cytoplasm is clear, and cell walls are distinct.<br />

eosinophilic (oncocytic) cytoplasm rather<br />

than the more characteristic clear cytoplasm<br />

{2258,2678}. This cell type may<br />

comprise the entire tumour and make it<br />

difficult to recognize as a clear cell adeno<strong>carcinoma</strong>.<br />

Endometrial clear cell adeno<strong>carcinoma</strong>s<br />

are not graded.<br />

Serous endometrial intraepithelial <strong>carcinoma</strong><br />

may also be seen in association<br />

with clear cell adeno<strong>carcinoma</strong>, and the<br />

associated benign endometrium is generally<br />

atrophic rather than hyperplastic.<br />

Prognosis and predictive factors<br />

Patients with clear cell adeno<strong>carcinoma</strong><br />

are frequently diagnosed in advanced<br />

clinical stages, and, thus, have a poor<br />

p rognosis {24,400,1595,3003}. On the<br />

other hand, clear cell adeno<strong>carcinoma</strong><br />

limited to the uterine corpus has a considerably<br />

better prognosis than serous<br />

adeno<strong>carcinoma</strong> of the same stage.<br />

Mixed adeno<strong>carcinoma</strong><br />

Definition<br />

Mixed adeno<strong>carcinoma</strong> is a tumour composed<br />

of an admixture of a type I<br />

(endometrioid <strong>carcinoma</strong>, including its<br />

variants, or mucinous <strong>carcinoma</strong>) and a<br />

type II <strong>carcinoma</strong> (serous or clear cell) in<br />

which the minor type must comprise at<br />

least 10% of the total volume of the<br />

tumour. The percentage of the minor<br />

component should be stated in the<br />

pathology report. It is generally accepted<br />

that 25% or more of a type II tumour<br />

implies a poor prognosis, although the<br />

significance of lesser proportions is not<br />

well understood {2646,2691}.<br />

Squamous cell <strong>carcinoma</strong><br />

Definition<br />

A primary <strong>carcinoma</strong> of the endometrium<br />

composed of squamous cells of varying<br />

degrees of differentiation.<br />

Epidemiology<br />

Squamous cell <strong>carcinoma</strong> of the<br />

endometrium is uncommon; only about<br />

seventy cases have been re p o rt e d<br />

{2397}.<br />

Clinical features<br />

Squamous cell <strong>carcinoma</strong> of the<br />

endometrium usually occurs in postmenopausal<br />

women and is often associated<br />

with cervical stenosis and pyometra.<br />

Histopathology<br />

Its histological appearance is essentially<br />

identical to that of squamous cell <strong>carcinoma</strong><br />

of the cervix and similarly includes<br />

a rare verrucous variant {2654}.<br />

Definition<br />

A <strong>carcinoma</strong> in which 90% or more is<br />

composed of cells resembling urothelial<br />

transitional cells. Lesser quantities of<br />

transitional cell diff e rentiation would<br />

qualify the tumour as a mixed <strong>carcinoma</strong><br />

with transitional cell differentiation.<br />

Epidemiology<br />

Transitional cell diff e rentiation in<br />

endometrial <strong>carcinoma</strong>s is extre m e l y<br />

uncommon with fewer than 15 cases<br />

reported {1554,1669}. Among patients<br />

with known racial origin, 50% are non-<br />

White (African, Hispanic, or Asian). The<br />

median age is 61.6 years (range 41-83<br />

years).<br />

Clinical features<br />

The main complaint at presentation is<br />

uterine bleeding.<br />

Macroscopy<br />

The tumours are often polypoid or papill<br />

a ry with a mean size of 3.5 cm.<br />

Infiltration of the myometrium is apparent<br />

in some cases.<br />

Histopathology<br />

The transitional cell component is often<br />

grade 2 or 3 and assumes a papillary<br />

configuration. It is always admixed with<br />

another type of <strong>carcinoma</strong>, most often<br />

endometrioid, but it may be clear cell or<br />

s e rous. HPV-associated koilocytotic<br />

changes occur rarely. Only the transitional<br />

cell component invades the<br />

myometrum deeply {1669}. All endometrial<br />

transitional cell <strong>carcinoma</strong>s are negative<br />

for cytokeratin 20 (CK20), but half<br />

a re positive for cytokeratin 7 (CK7)<br />

{1554,1669}.<br />

Differential diagnosis<br />

The diff e rential diagnosis includes<br />

metastatic transitional cell <strong>carcinoma</strong> fro m<br />

226 Tumours of the uterine corpus

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!